PAYX.NASDAQPaychex INC

Form 4: Paychex Director Joseph Doody Receives Future Equity Awards

Sentiment:

Insider Transaction Report


Paychex Director Joseph Doody was granted 164 restricted stock units and 670 stock options, effective July 15, 2025, as part of the company's incentive plan.

Summary

  • Joseph Doody, a Director at Paychex Inc. (PAYX), acquired 164 shares of common stock through an award of restricted stock units (RSUs) on July 15, 2025.
  • These RSUs were granted at a price of $0 and are subject to vesting pursuant to the Amended and Restated 2002 Stock Incentive Plan.
  • Following this transaction, Doody directly holds 925 shares of common stock.
  • An additional 22,997 shares of common stock are indirectly held through the Joseph G. Doody Revocable Living Trust.
  • Doody also acquired 670 stock options with an exercise price of $140.68, which become exercisable on July 15, 2026, and expire on July 14, 2035.
  • The filing also reports existing stock option holdings with various exercise prices and expiration dates, totaling 28,557 options, bringing the total options held to 29,227.

Sentiment

Score: 7

Explanation: The filing reports routine equity compensation for a director, which is generally positive as it aligns management's interests with shareholders. There are no negative implications or significant new information beyond the compensation details.

Positives

  • Director Joseph Doody received equity awards (RSUs and stock options), aligning his interests with shareholders.
  • The awards are part of an established incentive plan (Amended and Restated 2002 Stock Incentive Plan), indicating a structured approach to executive compensation.

Future Outlook

The filing indicates future vesting of restricted stock units and exercisability of stock options, aligning director incentives with long-term company performance.

Industry Context

This Form 4 filing reflects routine equity compensation practices common across publicly traded companies, particularly in the business services and human capital management sector where Paychex operates. Such awards are standard mechanisms to incentivize and retain key executives and directors by linking their compensation to the company's stock performance.

Comparison to Industry Standards

  • Equity awards like Restricted Stock Units (RSUs) and stock options are standard components of executive and director compensation packages in the U.S. market.
  • Companies such as ADP, Workday, and Ceridian HCM also utilize similar equity-based incentives to align management interests with shareholder value.
  • The grant of RSUs at a $0 price is typical for incentive awards, and the exercise prices of stock options are generally set at or above the market price on the grant date, which appears to be the case here with the new options at $140.68.

Related Party Transactions

  • The indirect ownership of 22,997 shares of common stock through the Joseph G. Doody Revocable Living Trust represents a related party holding.

Stakeholder Impact

  • Shareholders: The equity awards align the director's financial interests with shareholder value, potentially encouraging decisions that benefit stock performance.

Next Steps

  • Vesting of the 164 restricted stock units will occur as per the Amended and Restated 2002 Stock Incentive Plan.
  • The 670 newly acquired stock options will become exercisable on July 15, 2026.
  • Other existing stock options will become exercisable on their respective dates.

Key Dates

DateDescription
07/11/2020Date exercisable for 7,929 stock options with an exercise price of $85.33.
07/15/2021Date exercisable for 5,793 stock options with an exercise price of $73.53.
07/15/2022Date exercisable for 5,075 stock options with an exercise price of $112.67.
07/15/2023Date exercisable for 3,027 stock options with an exercise price of $115.00.
07/15/2024Date exercisable for 3,382 stock options with an exercise price of $120.86.
07/14/2025Date exercisable for 3,351 stock options with an exercise price of $121.63.
07/15/2025Date of acquisition for 164 restricted stock units and 670 stock options.
07/17/2025Signature date of the reporting person's attorney-in-fact.
07/15/2026Date exercisable for 670 newly acquired stock options.
07/10/2029Expiration date for 7,929 stock options with an exercise price of $85.33.
07/14/2030Expiration date for 5,793 stock options with an exercise price of $73.53.
07/14/2031Expiration date for 5,075 stock options with an exercise price of $112.67.
07/14/2032Expiration date for 3,027 stock options with an exercise price of $115.00.
07/14/2033Expiration date for 3,382 stock options with an exercise price of $120.86.
07/14/2034Expiration date for 3,351 stock options with an exercise price of $121.63.
07/14/2035Expiration date for 670 newly acquired stock options.

Recommendation

hold

Keywords

Paychex, PAYX, Form 4, SEC filing, insider trading, restricted stock units, RSU, stock options, equity award, director compensation, Joseph Doody

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.